CS175498B2 - - Google Patents

Info

Publication number
CS175498B2
CS175498B2 CS5170A CS517075A CS175498B2 CS 175498 B2 CS175498 B2 CS 175498B2 CS 5170 A CS5170 A CS 5170A CS 517075 A CS517075 A CS 517075A CS 175498 B2 CS175498 B2 CS 175498B2
Authority
CS
Czechoslovakia
Application number
CS5170A
Other languages
Czech (cs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CS175498B2 publication Critical patent/CS175498B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
CS5170A 1974-08-05 1975-07-22 CS175498B2 (en, 2012)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2438020A DE2438020A1 (de) 1974-08-05 1974-08-05 18-methyl-19-nor-20-keto-pregnane und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
CS175498B2 true CS175498B2 (en, 2012) 1977-05-31

Family

ID=5922668

Family Applications (2)

Application Number Title Priority Date Filing Date
CS5170A CS175498B2 (en, 2012) 1974-08-05 1975-07-22
CS215A CS175500B2 (en, 2012) 1974-08-05 1975-07-22

Family Applications After (1)

Application Number Title Priority Date Filing Date
CS215A CS175500B2 (en, 2012) 1974-08-05 1975-07-22

Country Status (17)

Country Link
US (1) US4029777A (en, 2012)
JP (1) JPS5141347A (en, 2012)
AT (1) AT345998B (en, 2012)
BE (1) BE832124A (en, 2012)
CA (1) CA1037027A (en, 2012)
CH (1) CH611910A5 (en, 2012)
CS (2) CS175498B2 (en, 2012)
DD (1) DD120192A5 (en, 2012)
DE (1) DE2438020A1 (en, 2012)
DK (1) DK136369C (en, 2012)
ES (1) ES439720A1 (en, 2012)
FR (1) FR2281123A1 (en, 2012)
GB (1) GB1512258A (en, 2012)
HU (1) HU171684B (en, 2012)
IL (1) IL47770A (en, 2012)
NL (1) NL7509326A (en, 2012)
SE (1) SE404804B (en, 2012)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61144199A (ja) * 1984-12-18 1986-07-01 Pioneer Electronic Corp スピ−カ用紙製振動部材の製造方法
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
EP0382790A4 (en) * 1987-08-25 1991-03-27 Kelvin W. Gee Compositions and methods for alleviating stress, anxiety and seizure activity
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
PL3498725T3 (pl) 2013-04-17 2021-11-08 Sage Therapeutics, Inc. 19-Nor C3,3-dipodstawiony C21-N-pirazolilo-steroid do zastosowania w terapii
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
LT2986624T (lt) 2013-04-17 2020-07-10 Sage Therapeutics, Inc. Neuroaktyvūs 9-nor steroidai, skirti gydymo metodams
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
RS61733B1 (sr) 2013-07-19 2021-05-31 Sage Therapeutics Inc Neuroaktivni steroidi, njihove kompozicije i upotrebe
WO2015027227A1 (en) 2013-08-23 2015-02-26 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
CN117024502A (zh) 2014-10-16 2023-11-10 萨奇治疗股份有限公司 靶向cns障碍的组合物和方法
RS60642B1 (sr) 2014-10-16 2020-09-30 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns-a
JP6893173B2 (ja) 2014-11-27 2021-06-23 セージ セラピューティクス, インコーポレイテッド Cns障害を処置するための組成物および方法
PT3250210T (pt) 2015-01-26 2021-03-26 Sage Therapeutics Inc Composições e métodos para o tratamento de distúrbios do snc
DK3258939T3 (da) 2015-02-20 2022-12-12 Sage Therapeutics Inc Neuroaktive steroider, sammensætninger og anvendelser heraf
MA45599A (fr) 2016-07-11 2019-05-15 Sage Therapeutics Inc Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
JP7065825B2 (ja) 2016-07-11 2022-05-12 セージ セラピューティクス, インコーポレイテッド C7、c12、およびc16置換神経刺激性ステロイドおよびそれらの使用方法
BR112020012712A8 (pt) * 2017-12-22 2022-03-03 Sage Therapeutics Inc Composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica e usos do referido composto para o tratamento de distúrbios do snc
WO2020243488A1 (en) 2019-05-31 2020-12-03 Sage Therapeutics, Inc. Neuroactive steroids and compositions thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1409239A (en) * 1971-11-11 1975-10-08 Glaxo Lab Ltd Process for the preparation of 3alpha-hydroxy-5alpha-steroids
BE791196A (fr) * 1971-11-11 1973-05-10 Glaxo Lab Ltd Nouveaux steroides, leur procede de preparation et leurs applications

Also Published As

Publication number Publication date
CS175500B2 (en, 2012) 1977-05-31
US4029777A (en) 1977-06-14
SE404804B (sv) 1978-10-30
CH611910A5 (en, 2012) 1979-06-29
DK344475A (da) 1976-02-06
DE2438020A1 (de) 1976-02-26
IL47770A0 (en) 1975-10-15
BE832124A (fr) 1976-02-05
AT345998B (de) 1978-10-10
DD120192A5 (en, 2012) 1976-06-05
ES439720A1 (es) 1977-03-01
AU8351575A (en) 1977-02-03
HU171684B (hu) 1978-02-28
DK136369B (da) 1977-10-03
FR2281123A1 (fr) 1976-03-05
CA1037027A (en) 1978-08-22
NL7509326A (nl) 1976-02-09
DK136369C (da) 1978-02-27
SE7508777L (sv) 1976-02-06
GB1512258A (en) 1978-05-24
JPS5141347A (en) 1976-04-07
ATA600475A (de) 1978-02-15
IL47770A (en) 1978-10-31

Similar Documents

Publication Publication Date Title
CS175498B2 (en, 2012)
FR2259045A1 (en, 2012)
FR2285883B1 (en, 2012)
FI752154A7 (en, 2012)
CS176624B1 (en, 2012)
FR2279624B1 (en, 2012)
FR2272439B1 (en, 2012)
FR2263213A1 (en, 2012)
DK149775A (en, 2012)
DK135352C (en, 2012)
DE2462653C2 (en, 2012)
CS178011B1 (en, 2012)
CS165253B1 (en, 2012)
CS170656B1 (en, 2012)
CH1465174A4 (en, 2012)
CH577320A5 (en, 2012)
CH575190A5 (en, 2012)
CH573085A5 (en, 2012)
CH564264A5 (en, 2012)
CH582363A5 (en, 2012)
DD115228A2 (en, 2012)
DD109911A1 (en, 2012)
CH578767A5 (en, 2012)
CH579078A5 (en, 2012)
CH593905A5 (en, 2012)